Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents

2017 
Abstract Alzheimer's Disease (AD) is a neurodegenerative brain disorder in which many biological dysfunctions are involved. Among them, two main types of lesions were discovered and widely studied: the amyloid plaques and the neurofibrillary tangles (NFTs). These two lesions are caused by the dysfunction and the accumulation of two proteins which are, respectively, the beta-amyloid peptide and the tau protein. The process that leads these two proteins to aggregate is complex and is the subject of current studies. After a brief description of the aggregation mechanisms, we will provide an overview of new therapeutic agents targeting the different dysfunctions and toxic species found during aggregation.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    123
    References
    93
    Citations
    NaN
    KQI
    []